<DOC>
	<DOCNO>NCT00912392</DOCNO>
	<brief_summary>Background : The effect exist treatment modality extensive disease small-cell lung cancer ( ED-SCLC ) unsatisfactory . Progress new strategy include efficient therapy want . Endostar® ( Rh-endostatin Injection ) may anti-tumor activity vascular endothelial growth factor initial treatment . This study design evaluate safety efficacy Endostar® combine etoposide-carboplatin ( EC ) chemotherapy patient ED-SCLC seek effective treatment .</brief_summary>
	<brief_title>Etoposide-Carboplatin Alone With Endostar Extensive Disease Small Cell Lung Cancer ( ED-SCLC )</brief_title>
	<detailed_description>Methods : In randomize , open label , placebo-controlled , multicentre trial , 120 patient plan enrolled random 2 arm ( 1:1 ) 10 center June 2009 June 2011 . The leader unit Shanghai Chest Hospital Affiliated Shanghai Jiao-Tong University . Main eligibility criterion histological cytological diagnosis ED-SCLC , age 18-75 year . All eligible patient receive etoposide-carboplatin ( EC ) alone endostar® 4-6 cycle ( 21 day 1 cycle ) . In arm1 patient receive endostar® 7.5mg/m2 day 1 day 14 , etoposide 60 mg/m2 day 1 day 5 carboplatin AUC 5 day 1 . In arm2 patient receive etoposide 60 mg/m2 day 1 day 5 carboplatin AUC 5 day 1 . Primary endpoint : progress free survival ( PFS ) . Secondary endpoint : progress free survival 6 month , overall survival ( OS ) , objective response rate ( ORR ) , clinical benefit rate ( CBR ) , Response duration , time progression ( TTP ) quality life ( QOL ) .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Small Cell Lung Carcinoma</mesh_term>
	<mesh_term>Etoposide phosphate</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<criteria>Histologically cytologically diagnose SCLC ; Age 1875 year ; Life expectancy ＞ 3 month ; Adequate hematologic , renal , hepatic function ; ECOG PS 02 ; Brain metastasis ; Clinically significant cardiovascular disease ; Presence hepatic renal dysfunction ; Evidence bleed diathesis coagulopathy Pregnant lactate woman ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>